glp 1 agonists and sglt2 inhibitors How Do (Sodium-Glucose Cotransporter 2) GLP-1 (Glucagon-Like Peptide-1) Receptor Reduce Cardiovascular Outcomes? Frontiers | Effects of SGLT2

The aims of this review are (1) to provide an overview of the clinical and biological overlap between neuropsychiatric long COVID and other fatigue-associated neuropsychiatric disorders, (2) to examine the shared molecular mechanisms of fatigue and depressive symptoms involving acetylcarnitine metabolism, and finally (3) to review the current evidence on acetylcarnitine supplementation studies as a treatment for fatigue-associated syndromes and pharmacological aspects of acetylcarnitine supplementation to provide a conceptual foundation for acetylcarnitine supplementation in neuropsychiatric long COVID syndrome

- -

It is often recommended to try a bucket theory approach: individual small triggers might be fine on their own, but when they add up (i.e., stress plus a high-histamine meal), the bucket overflows and causes a reaction

Other experts recommend a method called creatine loading, which involves starting with a larger dose for several days before reducing to a maintenance dose

2002 Jun;34(6):430-8